Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3441)
Vanda Pharmaceuticals Inc. (VNDA)
Moran Kevin Patrick — SVP, CFO & Treasurer
Shares
42,442
Price
$8.27
Total Value
$350.82K
Shares Held After
411,380
% of Holdings
9.4%
Vanda Pharmaceuticals Inc. (VNDA)
Williams Timothy — SVP & General Counsel
Shares
42,434
Price
$8.27
Total Value
$350.76K
Shares Held After
377,450
% of Holdings
10.1%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
66,363
Price
$28.14
Total Value
$1.87M
Shares Held After
793
% of Holdings
98.8%
Septerna, Inc. (SEPN)
Shaikhly Samira — Chief People Officer
Shares
4,090
Price
$27.51
Total Value
$112.50K
Shares Held After
67,156
% of Holdings
5.7%
Vanda Pharmaceuticals Inc. (VNDA)
Wijkstrom Joakim — SVP, Chief Marketing Officer
Shares
30,800
Price
$8.27
Total Value
$254.59K
Shares Held After
333,469
% of Holdings
8.5%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
3,048
Price
$89.66
Total Value
$273.28K
Shares Held After
122,029
% of Holdings
2.4%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,055
Price
$88.50
Total Value
$93.37K
Shares Held After
125,077
% of Holdings
0.8%
Kymera Therapeutics, Inc. (KYMR)
Gollob Jared — Chief Medical Officer
Shares
1,510
Price
$87.75
Total Value
$132.50K
Shares Held After
126,132
% of Holdings
1.2%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
1,107
Price
$89.66
Total Value
$99.25K
Shares Held After
77,729
% of Holdings
1.4%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
383
Price
$88.50
Total Value
$33.90K
Shares Held After
78,836
% of Holdings
0.5%
Kymera Therapeutics, Inc. (KYMR)
Chadwick Jeremy G — Chief Operating Officer
Shares
549
Price
$87.75
Total Value
$48.18K
Shares Held After
79,219
% of Holdings
0.7%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
4,113
Price
$89.66
Total Value
$368.76K
Shares Held After
237,483
% of Holdings
1.7%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
1,424
Price
$88.50
Total Value
$126.02K
Shares Held After
241,596
% of Holdings
0.6%
Kymera Therapeutics, Inc. (KYMR)
Jacobs Bruce N. — Chief Financial Officer
Shares
2,039
Price
$87.75
Total Value
$178.92K
Shares Held After
243,020
% of Holdings
0.8%
Annexon, Inc. (ANNX)
Overdorf Michael — EVP & CHIEF BUSINESS OFFICER
Shares
4,339
Price
$5.42
Total Value
$23.52K
Shares Held After
182,625
% of Holdings
2.3%
Annexon, Inc. (ANNX)
Yednock Ted — EVP & CHIEF INNOVATION OFFICER
Shares
5,566
Price
$5.42
Total Value
$30.17K
Shares Held After
154,161
% of Holdings
3.5%
Annexon, Inc. (ANNX)
Dananberg Jamie — CHIEF MEDICAL OFFICER
Shares
5,820
Price
$5.43
Total Value
$31.60K
Shares Held After
123,582
% of Holdings
4.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
10,052
Price
$90.13
Total Value
$905.99K
Shares Held After
675,341
% of Holdings
1.5%
Kymera Therapeutics, Inc. (KYMR)
Booth Bruce — Director
Shares
71,814
Price
$90.13
Total Value
$6.47M
Shares Held After
3,902,667
% of Holdings
1.8%
uniQure N.V. (QURE)
Potts Jeannette — Chief Legal Officer
Shares
8,578
Price
$9.95
Total Value
$85.35K
Shares Held After
106,495
% of Holdings
7.5%
Amylyx Pharmaceuticals, Inc. (AMLX)
Cohen Joshua B — Director
Shares
29,282
Price
$14.48
Total Value
$424.12K
Shares Held After
3,334,683
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
FRATES JAMES M — Chief Financial Officer
Shares
7,909
Price
$14.52
Total Value
$114.85K
Shares Held After
165,638
% of Holdings
4.6%
Annexon, Inc. (ANNX)
Lew Jennifer — EVP & CHIEF FINANCIAL OFFICER
Shares
5,565
Price
$5.42
Total Value
$30.16K
Shares Held After
170,700
% of Holdings
3.2%
Annexon, Inc. (ANNX)
ARTIS DEAN RICHARD — EVP & CHIEF SCIENTIFIC OFFICER
Shares
5,894
Price
$5.43
Total Value
$32.00K
Shares Held After
180,093
% of Holdings
3.2%
Amylyx Pharmaceuticals, Inc. (AMLX)
Klee Justin B. — Director
Shares
29,282
Price
$14.47
Total Value
$423.76K
Shares Held After
3,334,616
% of Holdings
0.9%
Amylyx Pharmaceuticals, Inc. (AMLX)
Bedrosian Camille L — Chief Medical Officer
Shares
6,461
Price
$14.58
Total Value
$94.21K
Shares Held After
169,295
% of Holdings
3.7%
Amylyx Pharmaceuticals, Inc. (AMLX)
Mazzariello Gina — Chief Legal Officer
Shares
6,844
Price
$14.52
Total Value
$99.38K
Shares Held After
134,430
% of Holdings
4.8%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
9,100
Price
$42.49
Total Value
$386.66K
Shares Held After
642,540
% of Holdings
1.4%
Spyre Therapeutics, Inc. (SYRE)
Turtle Cameron — Director
Shares
5,900
Price
$41.73
Total Value
$246.21K
Shares Held After
651,640
% of Holdings
0.9%
GENELUX Corp (GNLX)
Thomas John — Director
Shares
10,000
Price
$2.90
Total Value
$28.96K
Shares Held After
482,784
% of Holdings
2.0%
Ultragenyx Pharmaceutical Inc. (RARE)
Harris Erik — EVP & Chief Commercial Officer
Shares
10,539
Price
$22.80
Total Value
$240.29K
Shares Held After
89,515
% of Holdings
10.5%
Ultragenyx Pharmaceutical Inc. (RARE)
KAKKIS EMIL D — Director
Shares
54,404
Price
$22.80
Total Value
$1.24M
Shares Held After
658,994
% of Holdings
7.6%
Krystal Biotech, Inc. (KRYS)
ROMANO KATHRYN — Chief Accounting Officer
Shares
750
Price
$267.60
Total Value
$200.70K
Shares Held After
22,366
% of Holdings
3.2%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
200
Price
$9.98
Total Value
$2.00K
Shares Held After
1,122,391
% of Holdings
0.0%
Vir Biotechnology, Inc. (VIR)
SATO VICKI L — Director
Shares
21,800
Price
$9.50
Total Value
$207.19K
Shares Held After
1,122,591
% of Holdings
1.9%
FibroBiologics, Inc. (FBLG)
Davis Jason — Chief Financial Officer
Shares
70,000
Price
$0.41
Total Value
$28.97K
Shares Held After
70,000
% of Holdings
100.0%
IDEAYA Biosciences, Inc. (IDYA)
Stein Jeffrey — Director
Shares
50,000
Price
$32.96
Total Value
$1.65M
Shares Held After
54,281
% of Holdings
92.1%
Nurix Therapeutics, Inc. (NRIX)
Ring Christine — Chief Legal Officer
Shares
8,148
Price
$15.44
Total Value
$125.79K
Shares Held After
34,601
% of Holdings
19.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,675
Price
$33.81
Total Value
$90.44K
Shares Held After
237,584
% of Holdings
1.1%
Oruka Therapeutics, Inc. (ORKA)
Sandler Laura Lee — Chief Operating Officer
Shares
2,325
Price
$33.28
Total Value
$77.39K
Shares Held After
240,259
% of Holdings
1.0%
Contineum Therapeutics, Inc. (CTNM)
Lorrain Daniel S. — Chief Scientific Officer
Shares
4,170
Price
$15.01
Total Value
$62.59K
Shares Held After
151,882
% of Holdings
2.7%
Contineum Therapeutics, Inc. (CTNM)
Watkins Tim — CMO & Head of Development
Shares
3,611
Price
$15.02
Total Value
$54.22K
Shares Held After
0
% of Holdings
100.0%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
2,373
Price
$276.17
Total Value
$655.34K
Shares Held After
73,293
% of Holdings
3.1%
Krystal Biotech, Inc. (KRYS)
JANNEY DANIEL — Director
Shares
9,430
Price
$275.45
Total Value
$2.60M
Shares Held After
75,666
% of Holdings
11.1%
VERTEX PHARMACEUTICALS INC / MA (VRTX)
Bozic Carmen — EVP and CMO
Shares
2,329
Price
$480.31
Total Value
$1.12M
Shares Held After
37,734
% of Holdings
5.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
1,600
Price
$14.38
Total Value
$23.01K
Shares Held After
11,845,939
% of Holdings
0.0%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
214,839
Price
$14.12
Total Value
$3.03M
Shares Held After
11,844,339
% of Holdings
1.8%
Aurinia Pharmaceuticals Inc. (AUPH)
TANG KEVIN — Director
Shares
300,000
Price
$13.90
Total Value
$4.17M
Shares Held After
11,629,500
% of Holdings
2.6%
Arcutis Biotherapeutics, Inc. (ARQT)
Matsuda Masaru — Reporting Person's title: EVP, Chief Legal Officer
Shares
3,325
Price
$27.95
Total Value
$92.93K
Shares Held After
143,678
% of Holdings
2.3%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
182,891
Price
$15.99
Total Value
$2.92M
Shares Held After
2,276,354
% of Holdings
7.4%
Showing 1401–1450 of 3441 transactions (page 29 of 69)